Steroid sulfatase inhibitors for the topical treatment of skin disorders

Drugs of the Future

Volumn 33, Issue 7, 2008, Pages 597-606

  Reed, M J ^a   Purohit, A ^a   Woo, L W L ^b   Potter, B V L ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 [2 (ADAMANTYLIDENE)HYDROBENZOXAZOLE] O SULFAMATE; ANTIANDROGEN; ANTIBIOTIC AGENT; CYPROTERONE ACETATE; DERMATOLOGICAL AGENT; ENZYME INHIBITOR; ESTRONE 3 O SULFAMATE; INOCOTERONE ACETATE; MINOXIDIL; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; RETINOID DERIVATIVE; STERYL SULFATASE; STERYL SULFATASE INHIBITOR; STX 289; STX 64; UNCLASSIFIED DRUG;

ACNE VULGARIS; ALOPECIA; ANDROGEN SYNTHESIS; BREAST CANCER; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG PENETRATION; DRUG STABILITY; HIRSUTISM; HUMAN; HYPERTENSION; HYPERTRICHOSIS; NONHUMAN; PSORIASIS; REVIEW; SEBORRHEA; SKIN DISEASE; STEROID METABOLISM; STEROIDOGENESIS;

EID: 56749092298     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2008.033.07.1212711     Document Type: Review

References (79)

1. Reed, M.J., Purohit, A., Woo, L.W.L., Potter, B.V.L. The development of steroid sulphatase inhibitors. Endocr Relat Cancer 1996, 3: 9-23.
2. Reed, M.J., Purohit, A., Woo, L.W.L., Potter, B.V.L. Steroid sulfatase: Molecular biology, regulation and inhibition. Endocr Rev 2005, 26(2): 171-202.
3. Nussbaumer, P., Billich, A. Steroid sulfatase inhibitors. Expert Opin Ther Patents 2003, 13(5): 605-25.
4. Nussbaumer, P., Billich, A. Steroid sulfatase inhibitors. Med Res Rev 2004, 24(4): 529-76.
5. Stanway, S.J., Purohit, A., Woo, L.W. L. et al. Phase I study of STX64 (667 COUMATE) in breast cancer: The first study of a steroid sulfatase inhibitor. Clin Cancer Res 2006, 12(5): 1585-92.
6. Stanway, S.J., Delavault, P., Purohit, A., Woo, L.W.L., Thurieau, C., Potter, B.V.L., Reed, M.J. Steroid sulfatase: A new target for the endocrine therapy of breast cancer. Oncologist 2007, 12(4): 370-4.
7. Dodgson, K.S., Spencer, B., Thomas, J. Studies on sulphatases 6. The localisation of aryl sulphatase in the rat-liver cell. J Biochem 1954, 56(2): 177-81.
8. Dooley, T.P., Haldeman-Cahill, R., Joiner, J. Expression profiling of human sulfotrasferases and sulfatase gene superfamilies in epithelial and cultured cells. Biochem Biophys Res Commun 2000, 277(1): 236-45.
9. Labrie, F., Lun-The, V., Labrie, C., Pellefier, G., El-Alfy, M. Intracrinology and skin. Horm Res 2000, 54(5-6): 218-29.
10. Chen, W.C., Thiboutot, D., Zouboulis, C.C. Cutaneous androgen metabolism: Research and clinical perspectives. J Invest Dermatol 2002, 119(5): 992-1007.
11. Zouboulis, C.C. The human skin as a hormone target and an endocrine gland. Hormones 2004, 3(1): 9-2&
12. Howarth, N.M., Purohit, A., Vicker, N., Reed, M.J., Potter, B.V.L. Estrone-3-sulfamate mimics, inhibitors of estrone sulfatase activity: Homology model construction and docking studies. Biochemistry 2000, 41(50): 14801-14.
13. Duncan, L., Purohit, A., Howarth, N.M., Potter, B.V.L., Reed, M.J. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate - A potential therapeutic agent in breast cancer. Cancer Res 1993, 53(2): 298-303.
14. Howarth, N.M., Purohit, A., Reed, M.J., Potter, B.V.L. Estrone sulfamates: Potent inhibitors of estrone sulfatase with therapeutic potential. J Med Chem 1994, 37(2): 219-21.
15. Purohit, A., Williams, G.J., Howarth, N.N., Potter, B.V.L., Reed, M.J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 1995, 34(36): 11508-14.
16. Purohit, A., Williams, G.J., Roberts, C.J., Potter, B.V.L., Reed, M.J. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. Int J Cancer 1995, 63(1): 106-11.
17. Elger, W., Schwarz, S., Hedden, A., Reddersen, G., Schneider, B. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J Steroid Biochem Mol Biol 1995, 55(3-4): 395-403.
18. Woo, L.W.L., Purohit, A., Malini, B., Reed, M.J., Potter, B.V.L. Potent active site-directed inhibitors of steroid sulfatase by tricyclic coumarin-based sulfamates. Chem Biol 2000, 7(110): 773-91.
19. Woo, L.W.L., Purohit, A., Reed, M.J., Potter, B.V.L. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates. J Med Chem 1996, 39(7): 1349-51.
20. Ho, Y.T., Purohit, A., Vicker, N. Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates. Biochem Biophys Res Commun 2003, 305(4): 909-14.
21. Purohit, A., Woo, L.W.L., Potter, B.V.L., Reed, M.J. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumours by 667 COUMATE. Cancer Res 2000, 60(13): 3394-6.
22. Billich, A., Meingassner, J.G., Nussbaumer, P., Desrayand, S., Lam, C., Winishi, A., Schreiner, E. 6-[2-(Adamantylidene)-hydroxybenzoxozole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen and estrogen-dependent diseases. J Steroid Biochem Mol Biol 2004, 92(1-2): 29-37.
23. Daynes, R.A., Araneo, B.A., Dowell, T.A., Huang, K., Dudley, D. Regulation of murine lympokine production in vivo. J Exp Med 1999, 171(4): 979-96.
24. Rook, G.A.W., Hernandez-Pando, R., Lightman, S. Hormones, peripherally activated hormones and the regulation of Th1/Th2 balance. Immunol Today 1994, 15(7): 301-3.
25. Reed, M.J., Purohit, A., Singh, A., Chander, S.K. Androgenic modulation of the immune response. In: Menopause: The State of the Art in Research and Management. H.P.G. Schneider (Ed.). Parthenon Publishing Group, London, 2003, 23-7.
26. Shapiro, L.J., Weiss, R., Webster, D., France, J.T. X-linked ichthyosis due to steroid sulphatase deficiency. Lancet 1978, 1(8055): 70-2.
27. Hoyer, H., Lykkesfeldt, G., Ibsen, H.H., Brandrup, F. Ichthyosis of steroid sulphatase deficiency. Clinical study of 76 cases. Dermatologica 1986, 172(4): 184-90.
28. Hoffmann, R. Enzymology of the hair follicle. Eur J Dermatol 2001, 11(4): 296-300.
29. Essah, P.A., Wickham, E.P., Nunley, J.R., Nestler, J.E. Dermatology of androgen-related disorders. Clin Dermatol 2006, 24(4): 289-98.
30. Knockenhauer, E.S., Key, T.J., Kahsar-Miller, M., Waggoner, W., Boots, L.R., Azziz, R. Prevalence of the polycystic ovarian syndrome in unselected black and white women of the south-eastern United States: A prospective study. J Clin Endocrinol Metab 1998, 83(9): 3078-82.
31. Steinberger, E., Smith, K.D., Rodriguez-Rigau, L.J. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women. J Clin Endocrinol Metab 1984, 59(3): 471-7.
32. Haning, R.V. Using DHEAS to monitor androgen disorders. Contemp Obstet Gynecol 1981, 18: 117-32.
33. Hoffmann, R., Rot, A., Niiyama, N., Billlich, A. Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. J Invest Dermatol 2001, 117(6): 1342-8.
34. Hay, J.B., Hodgins, M.B. Metabolism of androgens in vitro by human facial and axillary skin. J Endocrinol 1973, 59(3): 475-86.
35. Hoffmann, R., Happle, R. Finasteride is the main inhibitor of 5 alpha-reductase activity in microdisected dermal papilla of human hair follicles. Arch Dermatol Res 1999, 291(2-3): 100-3.
36. Randall, V.A., Thornton, M.J., Hibberts, N.A., Loudon, B.S., Brinklow, B.R. Hormones and hair growth: Variations in androgen receptor content of dermal papilla cells cultured from human and red deer (Cerrus elaphus) hair follicles. J Invest Dermatol 1993, 101(1, Suppl.): 114S-20S.
37. Pitts, R.L. Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men. J Am Acad Dermatol 1987, 16(3, Pt. 1): 571-3.
38. Kasick, J.M., Bergfeld, W.F., Steck, W.D., Gupta, M.K. Adrenal androgenic female-pattern alopecia: Sex hormones and the balding women. Cleve Clin Q 1983, 50(2): 111-22.
39. Messenger, A.G., Rundegren, J. Minoxidil: Mechanisms of action on hair growth. Br J Dermatol 2004, 150(2): 186-94.
40. Price, V.H. Treatment of hair loss. N Engl J Med 1999, 341(13): 964-73.
41. Buhl, A.E., Waldon, D.J., Conrad, S.J. et al. Potassium channel conductance: A mechanism affecting hair growth both in vitro and in vivo. J Invest Dermatol 1992, 98(3): 315-9.
42. Harmon, C.S., Lutz, D., Ducote, J. Potassium channel openers stimulate DNA synthesis in mouse epidermal keratinocytes and whole hair follicle cultures. Skin Pharmacol 1993, 6(3): 170-8.
43. Buhl, A.E., Waldon, D.J., Baker, C.A., Johnson, G.A. Minoxidil sulfate in the active metabolite that stimulates hair follicles. J Invest Dermatol 1990, 95(5): 553-7.
44. Anderson, R.J., Kudlacek, P.E., Clemens, D.L. Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact 1998, 109(1-3): 53-67.
45. Johnson, G.A., Barsuhn, K.J., McCall, J.M. Sulfation of minoxidil by liver sulfotransferases. Biochem Pharmacol 1982, 31(18): 2949-54.
46. Krautheim, A., Gollnick, H.P.M. Acne: Topical treatment. Clin Dermatol 2004, 22(5): 398-407.
47. Stewart, M.E., Downing, D.T., Cook, J.S., Hansen, J.R., Strauss, J.S. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992, 128(10): 1345-8.
48. Yamamoto, A., Ito, M. Wax ester secretion rates and plasma dehydroepiandrosterone sulfate levels in children. J Dermatol 1994, 21(1): 59-60.
49. Zouboulis, C.C. Acne and sebaceous gland function. Clin Dermatol 2004, 22(5): 360-6.
50. Zouboulis, C.C., Degitz, K. Androgen action on human skin - From basic research to clinical significance. Exp Dermatol 2004, 14(Suppl. 4): 5-10.
51. 19-steroid sulfates in abdominal skin of healthy women and men. Acta Med Hung 1985, 42(1-2): 13-20.
52. Milewich, L., Southeimer, R.D., Herndon, J.H. Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris. Arch Dermatol 1990, 126(10): 1312-4.
53. Billich, A., Rot, A., Lam, C., Schmidt, J.B., Schuster, I. Immunohistochemical localisation of steroid sulfatase in acne lesions: Implications for the contribution of dehydroepiandrosterone sulfate to the pathogenesis of acne. Horm Res 2000, 532: 92-103, Abst 22.
54. Newman, S.P., Purohit, A., Ghilchik, M.W., Potter, B.V.L., Reed, M.J. Regulation of steroid sulphatase expression and activity in breast cancer. J Steroid Biochem Mol Biol 2000, 75(4-5): 259-64.
55. Thiboutot, D. Acne: Hormonal concepts. Clin Dermatol 2004, 22(5): 419-28.
56. Del Marmol, V., Teichmann, A., Gersten, K. The role of combined oral contraceptives in the management of acne and seborrhoea. Eur J Contracept Reprod Health 2004, 9(2): 107-24.
57. Lookingbill, D.P., Abrams, B.B., Ellis, C.N. et al. Inocoterone and acne. The effect of topical antiandrogen: Results of a multi-center clinical trial. Arch Dermatol 1992, 128(9): 1197-200.
58. Alesci, S., Bornstein, S.R. Neuroimmuno regulation of androgens in the adrenal gland and skin. Horm Res 2000, 54(5-6): 281-6.
59. Böhm, M., Lunger, A.T. The pilosebaceous unit is part of the skin immune system. Dermatology 1998, 196(1): 75-9.
60. Kanda, N., Watanabe, S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci 2005, 38(1): 1-7.
61. Namazi, M.R. Steroid sulfatase inhibitors as novel additions to the antipsoriatic armamentarium. Med Sci Monit 2005, 11(3): HY 7-9.
62. Krueger, J.G. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002, 46(1): 1-23.
63. Bos, J.D., De Rie, M.A. The pathogenesis of psoriasis: Immunological facts and speculations. Immunol Today 1999, 20(1): 40-6.
64. Griffiths, W.A.D., Judge, M.R., Leigh, I.M. Disorders of keratinization. In: Textbook of Dermatology. Champion, R.H., Burton, J.L., Burns, D.A., Breathnach, S.M. (Eds.). Blackwell Science, Oxford, 1998, 1490.
65. Eigen, E., Froebe, C. (Colgate Palmolive Co.). Deodorant compositions comprising inhibitors of odour producing axillary bacterial exoenzymes. US 5676937.
66. Zouboulis, C.C., Chen, W.-C., Thornton, M.J., Qin, K., Rosenfeld, R. Sexual hormones in human skin. Horm Metab Res 2007, 39(2): 85-95.
67. Kim, S.S., Rosenfeld, R.L. Hyperhydrosis as the only manifestation of hyperandrogenism in an adolescent girl. Arch Dermatol 2000, 139(3): 430-1.
68. Purohit, A., Woo, L.W.L., Singh, A., Winterborn, C.J., Potter, B.V.L., Reed, M.J. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Cancer Res 1996, 56(21): 4950-5.
69. Vicker, N., Ho, Y.T., Robinson, J., Woo, L.W.L., Purohit, A., Potter, B.V.L. Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II. Bioorg Med Chem Lett 2003, 13(5): 863-5.
70. Ireson, C.R., Chander, S.K., Purohit, A., Parish, D.C., Woo, L.W.L., Potter, B.V.L., Reed, M.J. Pharmacokinetics of the non-steroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats. Br J Cancer 2004, 91(7): 1399-404.
71. Ireson, C.R., Parish, D., Woo, L.W.L., Potter, B.V.L., Chander, S.K., Reed, M.J. Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo. J Steroid Biochem Mol Biol 2003, 84(2-3): 337-42.
72. OSIRIS Property Explorer, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil, Switzerland. Accessible at the portal http://www.actelion.com/uninet/www/wwwi_man_p.nsf/Content/ Technologies+Property+Explorer
73. Schmook, F.P., Meingassner, J.G., Billich, A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 2001, 215(1-2): 51-6.
74. Purohit, A., Chander, S.K., Woo, L.W.L., Parsons, M.F.C., Jhalli, R., Potter, B.V.L., Reed, M.J. Inhibition of steroid sulphatase activity via the percutaneous route: A new option for breast cancer therapy. Anticancer Res 2008, 28(3A): 1517-24.
75. Hall, G., Phillips, T.J. Estrogen and skin: The effects of estrogen, menopause and hormone replacement therapy on the skin. J Am Acad Dermatol 2005, 53(4): 555-68.
76. Verdier-Sevrain, S., Boute, F., Gilchrest, B. Biology of estrogens in skin: Implications for skin aging. Exp Dermatol 2006, 15(2): 83-94.
77. Sator, P.-G., Schmidt, J.B., Rabe, T., Zouboulis, C.C. Skin aging and sex hormones in women - Clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol 2004, 13(Suppl. 4): 36-40.
78. Mowad, C.M., Margolis, D.J., Halpern, A.C., Suri, B., Synnestvedt, M., Guzzo, C.A. Hormonal influences on women with psoriasis. Cutis 1998, 61(5): 257-60.
79. Swanbeck, G., Inerot, A., Martinsson, T., Wahlstrom, J. A population genetic study of psoriasis. Br J Dermatol 1994, 131(1): 32-9.